Basso Dias, Adriano http://orcid.org/0000-0003-4761-8708
Mirshahvalad, Seyed Ali http://orcid.org/0000-0003-2271-9764
Ortega, Claudia
Perlis, Nathan
Berlin, Alejandro
van der Kwast, Theodorus
Ghai, Sangeet
Jhaveri, Kartik
Metser, Ur
Haider, Masoom
Avery, Lisa
Veit-Haibach, Patrick
Article History
Received: 23 October 2022
Accepted: 7 February 2023
First Online: 21 February 2023
Declarations
:
: This was an ethics review board-approved, retrospective analysis of two prospective clinical trials (ClinicalTrials.gov Identifiers: NCT03535831 and NCT03149861).
: Informed consent was obtained from all individual participants included in the study.
: Alejandro Berlin: Participation on a DataSafety Monitoring Board or Advisory Board from Princess Margaret Cancer Center—University Health Network. Ur Metser: Consulting fees from POINT Biopharm; chair, Ontario PET Steering Committee and Ontario Health-Cancer Care Ontario. Patrick Veit-Haibach: Grants from Siemens Healthineers; support for attending meetings and/or travel from Siemens Healthineers; PET Center of Excellence committee of the Society of Nuclear Medicine member. The other authors have no relevant financial or non-financial interests to disclose.